{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T05:11:49Z","timestamp":1783833109419,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Known genetic disorders, such as Noonan syndrome and Down syndrome, can present in the neonatal period or early infancy with myeloproliferative disease (MPD) or abnormal myelopoiesis, which often self-resolves. This phenomenon results from an imbalance in differentiation and cell regulation caused by the genetic condition during perinatal hematopoiesis. Recently, <jats:italic>SH2B3<\/jats:italic> variants have also been associated with neonatal MPD. However, data on their clinical significance, particularly across the spectrum of extra-hematological manifestations, of <jats:italic>SH2B3<\/jats:italic> variants remain limited. Here, we describe the clinical features of ten children with SH2B3-associated disease, arising from germline biallelic <jats:italic>SH2B3<\/jats:italic> loss-of-function (LoF) mutations in eight patients and in two patients from monoallelic germline LoF variants with loss-of-heterozygosity in hematopoietic cells. Patients displayed a MPD in the first weeks of life, which was mostly self-limiting. Following the normalization of blood counts, thrombocytosis developed during childhood. Moreover, they presented with a multisystemic clinical features consisting in delayed growth, variable neurological impairment, autoimmune disorders. These data contribute to the definition of a clinical phenotype associated with germline biallelic <jats:italic>SH2B3<\/jats:italic> LoF variants presenting with neonatal MPD, with important implications for patient management and follow-up.<\/jats:p>","DOI":"10.1038\/s41431-025-01877-y","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T08:50:25Z","timestamp":1749199825000},"page":"1127-1135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Biallelic SH2B3 germline variants are associated with a neonatal myeloproliferative disease and multisystemic involvement"],"prefix":"10.1038","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4673-5876","authenticated-orcid":false,"given":"Davide","family":"Leardini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Flex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7032-4623","authenticated-orcid":false,"given":"Elliot","family":"Stieglitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0114-3620","authenticated-orcid":false,"given":"Sara","family":"Cerasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore Nicola","family":"Bertuccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Baccelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4328-9612","authenticated-orcid":false,"given":"Krisztia\u0301n","family":"Ka\u0301llay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Kjollerstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Batalha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Carpentieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Pedace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ciolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Hammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupama","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Innes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Rudelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Santini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Raddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kok-Hoi","family":"Teh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"De Vito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayami","family":"Yoshimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte M.","family":"Niemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Masetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"1877_CR1","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1086\/499925","volume":"78","author":"M Tartaglia","year":"2006","unstructured":"Tartaglia M, Martinelli S, Stella L, Bocchinfuso G, Flex E, Cordeddu V, et al. Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease. Am J Hum Genet. 2006;78:279\u201390.","journal-title":"Am J Hum Genet"},{"key":"1877_CR2","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3390\/cancers14030839","volume":"14","author":"D Leardini","year":"2022","unstructured":"Leardini D, Messelodi D, Muratore E, Baccelli F, Bertuccio SN, Anselmi L, et al. Role of CBL mutations in cancer and non-malignant phenotype. Cancers. 2022;14:839.","journal-title":"Cancers"},{"key":"1877_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1182\/hematology.2022000395","volume":"2022","author":"I Roberts","year":"2022","unstructured":"Roberts I. Leukemogenesis in infants and young children with trisomy 21. Hematol Am Soc Hematol Educ Program. 2022;2022:1\u20138.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"1877_CR4","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/leu.2017.139","volume":"31","author":"N Maslah","year":"2017","unstructured":"Maslah N, Cassinat B, Verger E, Kiladjian JJ, Velazquez L. The role of LNK\/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders. Leukemia. 2017;31:1661\u201370.","journal-title":"Leukemia"},{"key":"1877_CR5","first-page":"2391","volume":"109","author":"CM Niemeyer","year":"2024","unstructured":"Niemeyer CM, Erlacher M. SH2B3 alterations in a novel genetic condition, juvenile myelomonocytic leukemia, and myeloproliferative neoplasia. Haematologica. 2024;109:2391\u20134.","journal-title":"Haematologica"},{"key":"1877_CR6","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1182\/blood-2016-04-711150","volume":"128","author":"E Rumi","year":"2016","unstructured":"Rumi E, Harutyunyan AS, Pietra D, Feenstra JDM, Cavalloni C, Roncoroni E, et al. LNK mutations in familial myeloproliferative neoplasms. Blood. 2016;128:144\u20135.","journal-title":"Blood"},{"key":"1877_CR7","volume":"2022","author":"K Gundabolu","year":"2022","unstructured":"Gundabolu K, Dave BJ, Alvares CJ, Cannatella JJ, Bhatt VR, Maness LJ, et al. The Missing LNK: Evolution from cytosis to chronic myelomonocytic leukemia in a patient with multiple sclerosis and germline SH2B3 mutation. Case Rep Genet. 2022;2022:6977041.","journal-title":"Case Rep Genet"},{"key":"1877_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/ph15010024","volume":"15","author":"R Morris","year":"2021","unstructured":"Morris R, Butler L, Perkins A, Kershaw NJ, Babon JJ. The Role of LNK (SH2B3) in the Regulation of JAK-STAT signalling in haematopoiesis. Pharmaceuticals. 2021;15:24.","journal-title":"Pharmaceuticals"},{"key":"1877_CR9","doi-asserted-by":"crossref","unstructured":"Arfeuille C, Vial Y, Cadenet M, Caye-Eude A, Fenneteau O, Neven Q, et al. Germline bi-allelic SH2B3\/LNK alteration predisposes to a neonatal juvenile myelomonocytic leukemia-like disorder. Haematologica. 2024;109:2542\u201354.","DOI":"10.3324\/haematol.2023.283917"},{"key":"1877_CR10","doi-asserted-by":"crossref","unstructured":"Wintering A, Hecht A, Meyer J, Wong EB, H\u00fcbner J, Abelson S, et al. LNK\/SH2B3 as a novel driver in juvenile myelomonocytic leukemia. Haematologica. 2024;109:2533\u201341.","DOI":"10.3324\/haematol.2023.283776"},{"key":"1877_CR11","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1182\/blood-2013-05-500850","volume":"122","author":"A Perez-Garcia","year":"2013","unstructured":"Perez-Garcia A, Ambesi-Impiombato A, Hadler M, Rigo I, LeDuc CA, Kelly K, et al. Genetic loss of SH2B3 in acute lymphoblastic leukemia. Blood. 2013;122:2425\u201332.","journal-title":"Blood"},{"key":"1877_CR12","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/jha2.698","volume":"4","author":"P Blombery","year":"2023","unstructured":"Blombery P, Pazhakh V, Albuquerque AS, Maimaris J, Tu L, Briones Miranda B, et al. Biallelic deleterious germline SH2B3 variants cause a novel syndrome of myeloproliferation and multi-organ autoimmunity. EJHaem. 2023;4:463\u20139.","journal-title":"EJHaem"},{"key":"1877_CR13","doi-asserted-by":"publisher","first-page":"E231","DOI":"10.1002\/ajh.25552","volume":"94","author":"G Coltro","year":"2019","unstructured":"Coltro G, Lasho TL, Finke CM, Gangat N, Pardanani A, Tefferi A, et al. Germline SH2B3 pathogenic variant associated with myelodysplastic syndrome\/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis. Am J Hematol. 2019;94:E231\u20134.","journal-title":"Am J Hematol"},{"key":"1877_CR14","doi-asserted-by":"publisher","first-page":"E356","DOI":"10.1002\/ajh.24437","volume":"91","author":"GG Loscocco","year":"2016","unstructured":"Loscocco GG, Mannarelli C, Pacilli A, Fanelli T, Rotunno G, Gesullo F, et al. Germline transmission of LNKE208Q variant in a family with myeloproliferative neoplasms. Am J Hematol. 2016;91:E356.","journal-title":"Am J Hematol"},{"key":"1877_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-022-00414-y","volume":"16","author":"F Baccelli","year":"2022","unstructured":"Baccelli F, Leardini D, Muratore E, Messelodi D, Bertuccio SN, Chiriaco M, et al. Immune dysregulation associated with co-occurring germline CBL and SH2B3 variants. Hum Genom. 2022;16:40.","journal-title":"Hum Genom"},{"key":"1877_CR16","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/jha2.800","volume":"4","author":"G Vermeersch","year":"2023","unstructured":"Vermeersch G, Devos T, Devos H, Lambert F, Poppe B, Van Hecke S. Germline heterozygous SH2B3-mutations and (idiopathic) erythrocytosis: Detection of a previously undescribed mutation. EJHaem. 2023;4:1143\u20137.","journal-title":"EJHaem"},{"key":"1877_CR17","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/cei\/uxad002","volume":"211","author":"J Vandewalle","year":"2023","unstructured":"Vandewalle J, Desouter AK, Van der Auwera BJ, Tenoutasse S, Gillard P, De Block C, et al. CTLA4, SH2B3, and CLEC16A diversely affect the progression of early islet autoimmunity in relatives of Type 1 diabetes patients. Clin Exp Immunol. 2023;211:224\u201332.","journal-title":"Clin Exp Immunol"},{"key":"1877_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/jhg.2012.124","volume":"58","author":"JY Lee","year":"2013","unstructured":"Lee JY, Lee BS, Shin DJ, Woo Park K, Shin YA, Joong Kim K, et al. A genome-wide association study of a coronary artery disease risk variant. J Hum Genet. 2013;58:120\u20136.","journal-title":"J Hum Genet"},{"key":"1877_CR19","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/gene.2010.30","volume":"11","author":"A Alcina","year":"2010","unstructured":"Alcina A, Vandenbroeck K, Otaegui D, Saiz A, Gonzalez JR, Fernandez O, et al. The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis. Genes Immun. 2010;11:439\u201345.","journal-title":"Genes Immun"},{"key":"1877_CR20","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, et al. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140:1200\u201328.","journal-title":"Blood"},{"key":"1877_CR21","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem. 2004;25:1605\u201312.","journal-title":"J Comput Chem"},{"key":"1877_CR22","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/humu.23892","volume":"40","author":"L Wiel","year":"2019","unstructured":"Wiel L, Baakman C, Gilissen D, Veltman JA, Vriend G, Gilissen C. MetaDome: Pathogenicity analysis of genetic variants through aggregation of homologous human protein domains. Human Mutat. 2019;40:1030\u20138.","journal-title":"Human Mutat"},{"key":"1877_CR23","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1101\/gad.297135.117","volume":"31","author":"K Lv","year":"2017","unstructured":"Lv K, Jiang J, Donaghy R, Riling CR, Cheng Y, Chandra V, et al. CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies. Genes Dev. 2017;31:1007\u201323.","journal-title":"Genes Dev"},{"key":"1877_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ccr.2008.08.014","volume":"14","author":"N Kotecha","year":"2008","unstructured":"Kotecha N, Flores NJ, Irish JM, Simonds EF, Sakai DS, Archambeault S, et al. Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates. Cancer Cell. 2008;14:335\u201343.","journal-title":"Cancer Cell"},{"key":"1877_CR25","doi-asserted-by":"crossref","unstructured":"Chen Y, Gong S, Tang J, Wang X, Gao Y, Yang H, et al. LNK\/SH2B3 Loss Exacerbates the Development of Myeloproliferative Neoplasms in CBL-deficient Mice. Stem Cell Rev and Rep. 2024; Disponibile su: https:\/\/link.springer.com\/10.1007\/s12015-024-10825-0.","DOI":"10.1007\/s12015-024-10825-0"},{"key":"1877_CR26","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/j.1365-2141.2007.06958.x","volume":"140","author":"CM Niemeyer","year":"2008","unstructured":"Niemeyer CM, Kratz CP. Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options. Br J Haematol. 2008;140:610\u201324.","journal-title":"Br J Haematol"},{"key":"1877_CR27","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1084\/jem.20011883","volume":"195","author":"L Velazquez","year":"2002","unstructured":"Velazquez L, Cheng AM, Fleming HE, Furlonger C, Vesely S, Bernstein A, et al. Cytokine signaling and hematopoietic homeostasis are disrupted in Lnk-deficient mice. J Exp Med. 2002;195:1599\u2013611.","journal-title":"J Exp Med"},{"key":"1877_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ijlh.12506","volume":"38","author":"MF McMullin","year":"2016","unstructured":"McMullin MF. Congenital erythrocytosis. Int J Lab Hematol. 2016;38:59\u201365.","journal-title":"Int J Lab Hematol"},{"key":"1877_CR29","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1002\/hon.3023","volume":"40","author":"A Beghini","year":"2022","unstructured":"Beghini A, Leuzzi L, Abazari N, Bossi LE, Guido V, Trojani A, et al. A novel start-loss mutation of the SH2B3 gene in a family with myeloproliferative neoplasms. Hematol Oncol. 2022;40:1109\u201312.","journal-title":"Hematol Oncol"},{"key":"1877_CR30","doi-asserted-by":"publisher","first-page":"e20221080","DOI":"10.1084\/jem.20221080","volume":"221","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Morris R, Brown GJ, Lorenzo AMD, Meng X, Kershaw NJ, et al. Rare SH2B3 coding variants in lupus patients impair B cell tolerance and predispose to autoimmunity. J Exp Med. 2024;221:e20221080.","journal-title":"J Exp Med"},{"key":"1877_CR31","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/ng.102","volume":"40","author":"KA Hunt","year":"2008","unstructured":"Hunt KA, Zhernakova A, Turner G, Heap GAR, Franke L, Bruinenberg M, et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet. 2008;40:395\u2013402.","journal-title":"Nat Genet"},{"key":"1877_CR32","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.1093\/hmg\/ddp365","volume":"18","author":"MJH Coenen","year":"2009","unstructured":"Coenen MJH, Trynka G, Heskamp S, Franke B, van Diemen CC, Smolonska J, et al. Common and different genetic background for rheumatoid arthritis and coeliac disease. Hum Mol Genet. 2009;18:4195\u2013203.","journal-title":"Hum Mol Genet"},{"key":"1877_CR33","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.ajhg.2010.05.004","volume":"86","author":"A Zhernakova","year":"2010","unstructured":"Zhernakova A, Elbers CC, Ferwerda B, Romanos J, Trynka G, Dubois PC, et al. Evolutionary and functional analysis of celiac risk loci reveals SH2B3 as a protective factor against bacterial infection. Am J Hum Genet. 2010;86:970\u20137.","journal-title":"Am J Hum Genet"},{"key":"1877_CR34","doi-asserted-by":"publisher","first-page":"104214","DOI":"10.1016\/j.ejmg.2021.104214","volume":"64","author":"B Engel","year":"2021","unstructured":"Engel B, Laschtowitz A, Janik MK, Junge N, Baumann U, Milkiewicz P, et al. Genetic aspects of adult and pediatric autoimmune hepatitis: A concise review. Eur J Med Genet. 2021;64:104214.","journal-title":"Eur J Med Genet"},{"key":"1877_CR35","doi-asserted-by":"crossref","unstructured":"Michalek DA, Tern C, Zhou W, Robertson CC, Farber E, Campolieto P, et al. A multi-ancestry genome-wide association study in type 1 diabetes. Hum Mol Genet. 2024;33:958\u201368.","DOI":"10.1093\/hmg\/ddae024"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01877-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01877-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01877-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T13:04:57Z","timestamp":1758719097000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01877-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1877"],"URL":"https:\/\/doi.org\/10.1038\/s41431-025-01877-y","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"assertion":[{"value":"9 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written parental and patient consent had been obtained by the contributing centers following a review by the respective local Ethic Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}